Physician profile
Cesar A Moran
NPI 1376639393
$17,845.55
in general payments reported to CMS, 2019-2025
3 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,874 · 2022: $3,009 · 2023: $6,763 · 2024: $2,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,840 · Travel and Lodging: $974 · Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,840.00 |
| Travel and Lodging | $973.56 |
| Food and Beverage | $149.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $6,762.78 | 2023 | |
| Roche Diagnostics Corporation | $5,874.02 | 2019 | |
| Boehringer Ingelheim International Gmbh | $5,208.75 | 2022-2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.